Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

Because it’s under patent.

There was a temporary allowance for compounding it due to sustained manufacturer shortages but that is in the process of expiring.



Wasn’t GLP-1 discovered in 1984?


The first generation drug Exenatide's patent was filed in 1992, but got approved in 2005. The latest one is Tirzepatide, a dual agonist, approved in 2022. Expect soon for Retaglutide, a triple agnonist, in the market.


Not the newer ones that have lower risks of lifetime digestive issues.


As far as we know.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: